Literature DB >> 29275292

Cell-cycle Checkpoints and Aneuploidy on the Path to Cancer.

Elizabeth S Wenzel1, Amareshwar T K Singh2.   

Abstract

The cell cycle is a complex sequence of events through which a cell duplicates its contents and divides, and involves many regulatory proteins for proper cellular reproduction, including cyclin proteins and cyclin-dependent kinases, oncogenes and tumor-suppressor genes, and mitotic checkpoint proteins. Mutations of any of these regulatory mechanisms can lead to reproduction of cells carrying genetic mutations or abnormal numbers of chromosomes, resulting in genomic instability. Chromosomal instability, contributing to genomic instability, refers to abnormalities in the number of chromosomes, and leads to aneuploidy. The role of aneuploidy in cancer cell development is often disputed, as conflicting hypotheses and research make it unclear as to whether aneuploidy is a cause or consequence of cancer. Here, we present an overview of the importance of cell-cycle checkpoint regulation and chromosomal instability in the development of cancer, and discuss evidence for conflicting arguments for the role of aneuploidy in cancer, leading us to conclude that further investigation of this role would benefit our understanding of cancer development. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cell-cycle checkpoints; aneuploidy; cancer; cyclin-dependent kinases; cyclins; regulation; review

Mesh:

Substances:

Year:  2018        PMID: 29275292      PMCID: PMC5892633          DOI: 10.21873/invivo.11197

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  40 in total

Review 1.  Splitting the chromosome: cutting the ties that bind sister chromatids.

Authors:  K Nasmyth; J M Peters; F Uhlmann
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

Review 2.  Chromosome segregation and cancer: cutting through the mystery.

Authors:  P V Jallepalli; C Lengauer
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

Review 3.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

4.  High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene.

Authors:  A Lavigueur; V Maltby; D Mock; J Rossant; T Pawson; A Bernstein
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

5.  Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.

Authors:  Masayoshi Shichiri; Keigo Yoshinaga; Hisashi Hisatomi; Kenichi Sugihara; Yukio Hirata
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

6.  Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1.

Authors:  G Fang; H Yu; M W Kirschner
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 7.  Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes.

Authors:  K Paulsson; B Johansson
Journal:  Pathol Biol (Paris)       Date:  2006-05-11

8.  p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation.

Authors:  A R Clarke; S Gledhill; M L Hooper; C C Bird; A H Wyllie
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

Review 9.  The spindle checkpoint, aneuploidy, and cancer.

Authors:  Rajnish Bharadwaj; Hongtao Yu
Journal:  Oncogene       Date:  2004-03-15       Impact factor: 9.867

Review 10.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  37 in total

1.  Carcinogenic Pesticide Control via Hijacking Endosymbiosis; The Paradigm of DSB-A from Wolbachia pipientis for the Management of Otiorhynchus singularis.

Authors:  Thomas Kostaropoulos; Louis Papageorgiou; Spyridon Champeris Tsaniras; Dimitrios Vlachakis; Elias Eliopoulos
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

2.  Clinical and Molecular Characterization of Fanconi Anemia Patients in Turkey.

Authors:  Güven Toksoy; Dilek Uludağ Alkaya; Gülendam Bagirova; Şahin Avcı; Agharza Aghayev; Nilay Günes; Umut Altunoğlu; Yasemin Alanay; Seher Başaran; Ezgi G Berkay; Birsen Karaman; Tiraje T Celkan; Hilmi Apak; Hülya Kayserili; Beyhan Tüysüz; Zehra O Uyguner
Journal:  Mol Syndromol       Date:  2020-09-23

Review 3.  Cohesin dynamic association to chromatin and interfacing with replication forks in genome integrity maintenance.

Authors:  Sara Villa-Hernández; Rodrigo Bermejo
Journal:  Curr Genet       Date:  2018-03-16       Impact factor: 3.886

4.  ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance.

Authors:  Dimitrios Tsoumas; Sofia Nikou; Efstathia Giannopoulou; Spyridon Champeris Tsaniras; Chaido Sirinian; Ioannis Maroulis; Stavros Taraviras; Vassiliki Zolota; Haralabos P Kalofonos; Vasiliki Bravou
Journal:  Cancer Genomics Proteomics       Date:  2018 Mar-Apr       Impact factor: 4.069

5.  Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation.

Authors:  Kai Liu; Rui Lu; Qi Zhao; Jiaxing Du; Yuwei Li; Minying Zheng; Shiwu Zhang
Journal:  Med Oncol       Date:  2019-11-16       Impact factor: 3.064

Review 6.  Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications.

Authors:  Shazia Sofi; Umar Mehraj; Hina Qayoom; Shariqa Aisha; Syed Mohammad Basheeruddin Asdaq; Abdullah Almilaibary; Manzoor A Mir
Journal:  Med Oncol       Date:  2022-04-29       Impact factor: 3.064

Review 7.  Latest research progress on anticancer effect of baicalin and its aglycone baicalein.

Authors:  Lin Wang; Ting Feng; Zhilian Su; Chao Pi; Yumeng Wei; Ling Zhao
Journal:  Arch Pharm Res       Date:  2022-07-31       Impact factor: 6.010

Review 8.  The cell cycle, cancer development and therapy.

Authors:  Elaheh Jamasbi; Mona Hamelian; Mohammed Akhter Hossain; Kambiz Varmira
Journal:  Mol Biol Rep       Date:  2022-08-05       Impact factor: 2.742

9.  Hirsutanol A inhibits T-acute lymphocytic leukemia Jurkat cell viability through cell cycle arrest and p53-dependent induction of apoptosis.

Authors:  Fangfang Zhong; You Yang; Danwei Ren; Sili Long; Xiang Qin; Jing Liu; Yan Zeng; Wenjian Lan; Wenzhe Ma; Wenjun Liu
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

Review 10.  The palette of techniques for cell cycle analysis.

Authors:  Anna E Eastman; Shangqin Guo
Journal:  FEBS Lett       Date:  2020-05-22       Impact factor: 3.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.